23rd Edition Strategic Project & Portfolio Management For Pharma

Taking advantage of new opportunities, technologies and organisational models to accelerate project portfolio delivery

The marcus evans23rd Edition Strategic Project & Portfolio Management for Pharma conference taking place on 25-27 January, 2023, in Barcelona, Spain, will bring together leading project and portfolio managers to discuss how they’re supporting critical decision-making capabilities through implementing  the  best  methodologies, technologies, and organizational models. The event will explore how you can maximize the value  and  resilience  of  your  portfolio  through the  best  practices  in  project prioritization  and  resource  allocation, focusing  on  creating  the  ideal  balance  between  risks  and  opportunities. All these topics and more will be discussed in an open and engaging environment, with plenty of networking and brainstorming during the interactive sessions. At the end you’ll walk away with actionable insights on how to build effective management capabilities and navigate critical decisions.

Attending This Premier marcus evans Conference Will Enable You to:

• Articulateyour priorities better in an uncertain environment
• Balance financial & scientific value to ensure project & portfolio alignment with strategic goals
• Explore the impact of data analytics, AI and machine learning applied to R&D portfolio management
• Maximiseportfolio value under limited budget
• Explorehow to manage capacities and prioritise between projects
• Align R&D with Commercial with an integrated data strategy between projects Manage innovation and risk in the early pipeline

Best Practices and Case Studies from:

• Tom Halliwell, Senior Vice President & Head of Operations, Ariceum Therapeutics, United Kingdom
• Gilles Brackman,Vice President of R&D, Flen Health, Belgium
• Simone Frandsen,Director R&D Portfolio and Strategy, LEO Pharma, Denmark
• Nathalie Mondoly,Director, Pharmaceutical Development Transformation and Enterprise Excellence Pharmaceutical Development – R&D, Ipsen, France
• Thorsten Knoechel,Head, R&D Governance Operations,Merck, Germany
• Heidi Peachey,Portfolio Manager, Cancer Research UK, United Kingdom

€200 discount is available for Innoget members! For more information please contact Ria Kiayia, Digital Media and PR Marketing Executive at riak@marcusevanscy.com or visit the event website: https://bit.ly/3MHXJq2